3,4-Methylenedioxy-N-methoxyamphetamine
From Wikipedia, the free encyclopedia
(Redirected from MDMEO)
Names | |
---|---|
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider | |
|
|
|
|
Properties | |
C11H15NO3 | |
Molar mass | 209.25 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO, MDMEOA, or MDMeOA) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEO may be found as white crystals. It produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.
See also[edit]
References[edit]
External links[edit]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |